TP53 and Parkinson disease: p53 signaling pathway, cell cycle, DNA repair, and regulation of the actin cytoskeleton were enriched in the high-risk group, whereas the low-risk group had higher levels of Parkinson’s disease, ribosomal, Alzheimer’s disease, and neuroactive ligand-receptor interactions.